COVID-19 현재 치료 시장 보고서(2026년)

COVID-19 current therapy refers to the treatments and interventions employed to manage symptoms and reduce the severity of COVID-19. These therapies help alleviate respiratory distress, prevent complications, and support recovery in affected individuals. Key approaches include antiviral medications, corticosteroids, and supportive care.

The main types of drugs in COVID-19 current therapy include antivirals, monoclonal antibodies, corticosteroids, supplements, antimalarials, interferons and interleukin inhibitors, other anti-infective drugs, and more. Antivirals are medications designed to inhibit viral growth and replication by targeting specific stages of the viral life cycle or interfering with viral processes. They can be administered through various routes, including oral and intravenous. These therapies are used across hospitals, clinics, research institutes, and other healthcare settings.

Tariffs have influenced the COVID-19 current therapy market by increasing the cost of imported antiviral drugs, monoclonal antibodies, corticosteroids, and digital monitoring devices. Hospital and clinic segments in North America, Europe, and parts of Asia relying heavily on imports are most affected. This has led to higher treatment costs and temporary supply chain disruptions. On the positive side, tariffs have encouraged local manufacturing, domestic production of therapies, and innovation in cost-effective treatment alternatives.

The covid-19 current therapy market research report is one of a series of new reports from The Business Research Company that provides covid-19 current therapy market statistics, including covid-19 current therapy industry global market size, regional shares, competitors with a covid-19 current therapy market share, detailed covid-19 current therapy market segments, market trends and opportunities, and any further data you may need to thrive in the covid-19 current therapy industry. This covid-19 current therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The covid-19 current therapy market size has declined steeply in recent years. It will decline from $2.35 billion in 2025 to $1.57 billion in 2026 at a compound annual growth rate (CAGR) of -33.2%. The decline in the historic period can be attributed to sudden outbreak of covid-19, high hospitalization rates, limited initial therapeutic options, decreasing government and healthcare initiatives, less emergency approvals for drugs.

The covid-19 current therapy market size is expected to see steep decline in the next few years. It will decline to $0.31 billion in 2030 at a compound annual growth rate (CAGR) of -33.2%. The decline in the forecast period can be attributed to decreasing telemedicine adoption for covid-19 management, less expansion of home care services. Major trends in the forecast period include rising adoption of antiviral and monoclonal antibody therapies, increased use of corticosteroids for severe covid-19 cases, growth in home care and remote patient monitoring for covid-19, expansion of supplement and immune support therapies, integration of combination and experimental therapies in treatment protocols.

The expansion of the healthcare infrastructure is expected to propel the growth of the COVID-19 current therapy market going forward. The healthcare industry refers to amalgamating and integrating the economic system's sectors that offer products and services for curing, preventing, rehabilitating, and providing palliative care for patients. Healthcare infrastructure is pivotal for the effective implementation of COVID-19 therapies, ensuring timely patient care, supporting research and clinical trials, and providing essential resources for optimal treatment delivery. For instance, in May 2023, according to the American Health Care Association, a US-based nonprofit organization, the number of hospitals in the US increased to 6,129 from 6,093 in 2022. Furthermore, in May 2023, according to a report published by the Office for National Statistics, a UK-based government department, healthcare spending in the UK saw a significant of 9.4% in nominal terms and 9.7% in real terms. Therefore, the expansion of the healthcare industry is driving the growth of the COVID-19 current therapy market.

Major companies operating in the COVID-19 current therapy market are increasing their focus on introducing innovative products, such as COVID-19 oral antiviral treatment, to gain a competitive edge in the market. Antiviral treatment refers to the use of medications designed to inhibit the replication and spread of viruses within the body. For instance, in April 2024, Invivyd, a US-based company focuses on developing antibody-based therapies to address serious viral infectious diseases update on the launch of PEMGARDA(TM). Following its emergency use authorization (EUA) from The U.S. Food and Drug Administration (FDA). PEMGARDA quickly became available for commercial use. This treatment is aimed at preventing COVID-19 in individuals with moderate-to-severe immune compromise.

In July 2024, CureVac N.V., a Netherlands-based biotechnology company, partnered with GlaxoSmithKline plc (GSK), to restructure their mRNA vaccine collaboration into a new licensing agreement. With this partnership, CureVac N.V. and GlaxoSmithKline plc (GSK) aim to optimize the development and commercialization of mRNA-based vaccines by combining CureVac's mRNA technology platform with GSK's global regulatory, manufacturing, and commercial capabilities, enabling faster vaccine development, improved access, and expanded market reach worldwide. GlaxoSmithKline plc (GSK) is a UK-based pharmaceutical company that specializes in developing and commercializing vaccines, medicines, and consumer healthcare products.

Major companies operating in the covid-19 current therapy market are Gilead Sciences Inc., Ipca Laboratories Limited, Zydus Cadila, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, AbbVie, Glenmark Pharmaceuticals Limited, Eli Lilly and Company, Wallace Pharmaceuticals Inc., Canary Health Technologies, Thermo Fisher Scientific

North America is the largest region in the COVID-19 current therapy market in 2025. Middle East is expected to be the fastest-growing region in the global COVID-19 current therapy market share during the forecast period. The regions covered in the covid-19 current therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the covid-19 current therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The COVID-19 current therapy market includes revenues earned by entities by tocilizumab, favipiravir, and ivermectin. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

COVID-19 Current Therapy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses covid-19 current therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for covid-19 current therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The covid-19 current therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Drug Type: Antiviral; Monoclonal Antibodies; Corticosteroid; Supplements; Antimalarial; Interferons And Interleukin Inhibitors; Other Anti-Infective Drugs
• 2) By Route Of Administration: Oral; Intravenous
• 3) By End-User: Hospitals; Clinics; Home Care; Others
• Subsegments:
• 1) By Antiviral: Remdesivir; Oseltamivir; Favipiravir; Nirmatrelvir Or ritonavir (Paxlovid)
• 2) By Monoclonal Antibodies: Bamlanivimab; Casirivimab Or Imdevimab (REGEN-COV); Sotrovimab; Etesevimab
• 3) By Corticosteroid: Dexamethasone; Hydrocortisone; Prednisone
• 4) By Supplements: Vitamin D; Vitamin C; Zinc; Quercetin
• 5) By Antimalarial: Hydroxychloroquine; Chloroquine
• 6) By Interferons and Interleukin Inhibitors: Interferon beta-1a; Interleukin-6 inhibitors
• 7) By Other Anti-Infective Drugs: Antibiotics; Antifungal Agents
• Companies Mentioned: Gilead Sciences Inc.; Ipca Laboratories Limited; Zydus Cadila; Regeneron Pharmaceuticals Inc.; Sun Pharmaceutical Industries Limited; AbbVie; Glenmark Pharmaceuticals Limited; Eli Lilly and Company; Wallace Pharmaceuticals Inc.; Canary Health Technologies; Thermo Fisher Scientific
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. COVID-19 Current Therapy Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global COVID-19 Current Therapy Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. COVID-19 Current Therapy Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global COVID-19 Current Therapy Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Artificial Intelligence & Autonomous Intelligence
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Antiviral And Monoclonal Antibody Therapies
  • 4.2.2 Increased Use Of Corticosteroids For Severe Covid-19 Cases
  • 4.2.3 Growth In Home Care And Remote Patient Monitoring For Covid-19
  • 4.2.4 Expansion Of Supplement And Immune Support Therapies
  • 4.2.5 Integration Of Combination And Experimental Therapies In Treatment Protocols

5. COVID-19 Current Therapy Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Home Care
• 5.4 Government Healthcare Facilities
• 5.5 Long-Term Care Centers

6. COVID-19 Current Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global COVID-19 Current Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global COVID-19 Current Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global COVID-19 Current Therapy Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global COVID-19 Current Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global COVID-19 Current Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global COVID-19 Current Therapy Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. COVID-19 Current Therapy Market Segmentation

• 9.1. Global COVID-19 Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Antiviral, Monoclonal Antibodies, Corticosteroid, Supplements, Antimalarial, Interferons And Interleukin Inhibitors, Other Anti-Infective Drugs
• 9.2. Global COVID-19 Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral, Intravenous
• 9.3. Global COVID-19 Current Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Clinics, Home Care, Other End-Users
• 9.4. Global COVID-19 Current Therapy Market, Sub-Segmentation Of Antiviral, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Remdesivir, Oseltamivir, Favipiravir, Nirmatrelvir Or Ritonavir (Paxlovid)
• 9.5. Global COVID-19 Current Therapy Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bamlanivimab, Casirivimab Or Imdevimab (REGEN-COV), Sotrovimab, Etesevimab
• 9.6. Global COVID-19 Current Therapy Market, Sub-Segmentation Of Corticosteroid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Dexamethasone, Hydrocortisone, Prednisone
• 9.7. Global COVID-19 Current Therapy Market, Sub-Segmentation Of Supplements, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Vitamin D, Vitamin C, Zinc, Quercetin
• 9.8. Global COVID-19 Current Therapy Market, Sub-Segmentation Of Antimalarial, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hydroxychloroquine, Chloroquine
• 9.9. Global COVID-19 Current Therapy Market, Sub-Segmentation Of Interferons And Interleukin Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Interferon Beta-1a, Interleukin-6 Inhibitors
• 9.10. Global COVID-19 Current Therapy Market, Sub-Segmentation Of Other Anti-Infective Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Antibiotics, Antifungal Agents

10. COVID-19 Current Therapy Market Regional And Country Analysis

• 10.1. Global COVID-19 Current Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global COVID-19 Current Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific COVID-19 Current Therapy Market

• 11.1. Asia-Pacific COVID-19 Current Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China COVID-19 Current Therapy Market

• 12.1. China COVID-19 Current Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India COVID-19 Current Therapy Market

• 13.1. India COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan COVID-19 Current Therapy Market

• 14.1. Japan COVID-19 Current Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia COVID-19 Current Therapy Market

• 15.1. Australia COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia COVID-19 Current Therapy Market

• 16.1. Indonesia COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea COVID-19 Current Therapy Market

• 17.1. South Korea COVID-19 Current Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan COVID-19 Current Therapy Market

• 18.1. Taiwan COVID-19 Current Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia COVID-19 Current Therapy Market

• 19.1. South East Asia COVID-19 Current Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe COVID-19 Current Therapy Market

• 20.1. Western Europe COVID-19 Current Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK COVID-19 Current Therapy Market

• 21.1. UK COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany COVID-19 Current Therapy Market

• 22.1. Germany COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France COVID-19 Current Therapy Market

• 23.1. France COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy COVID-19 Current Therapy Market

• 24.1. Italy COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain COVID-19 Current Therapy Market

• 25.1. Spain COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe COVID-19 Current Therapy Market

• 26.1. Eastern Europe COVID-19 Current Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia COVID-19 Current Therapy Market

• 27.1. Russia COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America COVID-19 Current Therapy Market

• 28.1. North America COVID-19 Current Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA COVID-19 Current Therapy Market

• 29.1. USA COVID-19 Current Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada COVID-19 Current Therapy Market

• 30.1. Canada COVID-19 Current Therapy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America COVID-19 Current Therapy Market

• 31.1. South America COVID-19 Current Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil COVID-19 Current Therapy Market

• 32.1. Brazil COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East COVID-19 Current Therapy Market

• 33.1. Middle East COVID-19 Current Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa COVID-19 Current Therapy Market

• 34.1. Africa COVID-19 Current Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa COVID-19 Current Therapy Market, Segmentation By Drug Type, Segmentation By Route Of Administration, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. COVID-19 Current Therapy Market Regulatory and Investment Landscape

36. COVID-19 Current Therapy Market Competitive Landscape And Company Profiles

• 36.1. COVID-19 Current Therapy Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. COVID-19 Current Therapy Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. COVID-19 Current Therapy Market Company Profiles
  • 36.3.1. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Ipca Laboratories Limited Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Zydus Cadila Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Sun Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis

37. COVID-19 Current Therapy Market Other Major And Innovative Companies

• AbbVie, Glenmark Pharmaceuticals Limited, Eli Lilly and Company, Wallace Pharmaceuticals Inc., Canary Health Technologies, Thermo Fisher Scientific

38. Global COVID-19 Current Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The COVID-19 Current Therapy Market

40. COVID-19 Current Therapy Market High Potential Countries, Segments and Strategies

• 40.1 COVID-19 Current Therapy Market In 2030 - Countries Offering Most New Opportunities
• 40.2 COVID-19 Current Therapy Market In 2030 - Segments Offering Most New Opportunities
• 40.3 COVID-19 Current Therapy Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer